These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29699387)

  • 101. Pro-survival role of p62 during granulocytic differentiation of acute myeloid leukemia cells.
    Ségal-Bendirdjian E; Tschan MP; Reiffers J; Djavaheri-Mergny M
    Mol Cell Oncol; 2014; 1(4):e970066. PubMed ID: 27308379
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Specific cellular signal-transduction responses to in vivo combination therapy with ATRA, valproic acid and theophylline in acute myeloid leukemia.
    Skavland J; Jørgensen KM; Hadziavdic K; Hovland R; Jonassen I; Bruserud O; Gjertsen BT
    Blood Cancer J; 2011 Feb; 1(2):e4. PubMed ID: 22829110
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Retinoic Acids in the Treatment of Most Lethal Solid Cancers.
    Costantini L; Molinari R; Farinon B; Merendino N
    J Clin Med; 2020 Jan; 9(2):. PubMed ID: 32012980
    [TBL] [Abstract][Full Text] [Related]  

  • 104. "Modulating Phosphoinositide Profiles as a Roadmap for Treatment in Acute Myeloid Leukemia".
    Ratti S; Evangelisti C; Mongiorgi S; De Stefano A; Fazio A; Bonomini F; Follo MY; Faenza I; Manzoli L; Sheth B; Vidalle MC; Kimber ST; Divecha N; Cocco L; Fiume R
    Front Oncol; 2021; 11():678824. PubMed ID: 34109125
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Short hairpin RNA screen reveals bromodomain proteins as novel targets in acute myeloid leukemia.
    Blobel GA; Kalota A; Sanchez PV; Carroll M
    Cancer Cell; 2011 Sep; 20(3):287-8. PubMed ID: 21907920
    [TBL] [Abstract][Full Text] [Related]  

  • 106. The ncBAF Complex Regulates Transcription in AML Through H3K27ac Sensing by BRD9.
    Klein DC; Lardo SM; Hainer SJ
    Cancer Res Commun; 2024 Jan; 4(1):237-252. PubMed ID: 38126767
    [TBL] [Abstract][Full Text] [Related]  

  • 107. EVI1-mediated Programming of Normal and Malignant Hematopoiesis.
    Lux S; Milsom MD
    Hemasphere; 2023 Oct; 7(10):e959. PubMed ID: 37810550
    [No Abstract]   [Full Text] [Related]  

  • 108. Tissue Factor-Enriched Neutrophil Extracellular Traps Promote Immunothrombosis and Disease Progression in Sepsis-Induced Lung Injury.
    Zhang H; Zhou Y; Qu M; Yu Y; Chen Z; Zhu S; Guo K; Chen W; Miao C
    Front Cell Infect Microbiol; 2021; 11():677902. PubMed ID: 34336711
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Gene Transcription as a Therapeutic Target in Leukemia.
    Khamidullina AI; Varlamova EA; Hammoud NA; Yastrebova MA; Bruter AV
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298959
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Chromosomal Instability in Acute Myeloid Leukemia.
    de Oliveira Lisboa M; Brofman PRS; Schmid-Braz AT; Rangel-Pozzo A; Mai S
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071283
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Characterization of NADPH Oxidase Expression and Activity in Acute Myeloid Leukemia Cell Lines: A Correlation with the Differentiation Status.
    Dakik H; El Dor M; Leclerc J; Kouzi F; Nehme A; Deynoux M; Debeissat C; Khamis G; Ducrocq E; Ibrik A; Stasia MJ; Raad H; Rezvani HR; Gouilleux F; Zibara K; Herault O; Mazurier F
    Antioxidants (Basel); 2021 Mar; 10(3):. PubMed ID: 33807114
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Targeting Epigenetic 'Readers' with Natural Compounds for Cancer Interception.
    Damiani E; Duran MN; Mohan N; Rajendran P; Dashwood RH
    J Cancer Prev; 2020 Dec; 25(4):189-203. PubMed ID: 33409252
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Efficacy of All-Trans-Retinoic Acid in High-Risk Acute Myeloid Leukemia with Overexpression of EVI1.
    Paubelle E; Plesa A; Hayette S; Elhamri M; Zylbersztejn F; Hermine O; Salles G; Thomas X
    Oncol Ther; 2019 Dec; 7(2):121-130. PubMed ID: 32699982
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Oncogenic Roles Of A Histone Methyltransferase SETDB2 In AML1-ETO Positive AML.
    Mu G; Chen F
    Cancer Manag Res; 2020; 12():783-792. PubMed ID: 32099474
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Efficient Differentiation of Mouse Induced Pluripotent Stem Cells into Alveolar Epithelium Type II with a BRD4 Inhibitor.
    Momozane T; Fukui E; Funaki S; Fujii M; Kinehara Y; Ito E; Miyagawa S; Ohno Y; Sawa Y; Okumura M; Shintani Y
    Stem Cells Int; 2019; 2019():1271682. PubMed ID: 31949433
    [TBL] [Abstract][Full Text] [Related]  

  • 116. The Bromodomain Inhibitor JQ1 Enhances the Responses to All-
    Kang C; Kim CY; Kim HS; Park SP; Chung HM
    Int J Stem Cells; 2018 May; 11(1):131-140. PubMed ID: 29699387
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Enzastaurin enhances ATRA-induced differentiation of acute myeloid leukemia cells.
    Li ZY; Liang C; Ding M; Weng XQ; Sheng Y; Wu J; Lu H; Cai X
    Am J Transl Res; 2020; 12(12):7836-7854. PubMed ID: 33437364
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Lyn, a tyrosine kinase closely linked to the differentiation status of primary acute myeloid leukemia blasts, associates with negative regulation of all-trans retinoic acid (ATRA) and dihydroxyvitamin D3 (VD3)-induced HL-60 cells differentiation.
    Iriyama N; Yuan B; Hatta Y; Takagi N; Takei M
    Cancer Cell Int; 2016; 16():37. PubMed ID: 27182202
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Trametinib enhances ATRA-induced differentiation in AML cells.
    Lu H; Li ZY; Ding M; Liang C; Weng XQ; Sheng Y; Wu J; Cai X
    Leuk Lymphoma; 2021 Dec; 62(14):3361-3372. PubMed ID: 34355652
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Reprogramming acute myeloid leukemia into sensitivity for retinoic-acid-driven differentiation.
    van Gils N; Verhagen HJMP; Smit L
    Exp Hematol; 2017 Aug; 52():12-23. PubMed ID: 28456748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.